Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (221-230 of 354) with videos related to

Pageof 36
Sort By:
Pharmacoepidemiology and Drug Safety|March 26, 2011
Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signalsPernelle Noize, Haleh Bagheri, Geneviève Durrieu, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 30, 2019
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDSPatrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
The British Journal of Nutrition|July 23, 2009
Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavonesSébastien Vergne, Patrick Sauvant, Valérie Lamothe, et al.
British Journal of Clinical Pharmacology|August 22, 2016
Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility studyLudivine Orriols, Audrey Luxcey, Benjamin Contrand, et al.
British Journal of Clinical Pharmacology|February 18, 2015
Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting systemEmanuel Raschi, Elisabetta Poluzzi, Ariola Koci, et al.
International Journal of Geriatric Psychiatry|September 2, 2011
Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly populationFabienne Bazin, Pernelle Noize, Jean-François Dartigues, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims databasePatrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 21, 2021
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDSPatrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
Biopharmaceutics & Drug Disposition|January 19, 2006
Myocardium distribution of sertindole and its metabolite dehydrosertindole in guinea-pigsMireille Canal-Raffin, Karine Titier, Evelyne Déridet, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Pageof 36

Showing results (221-230 of 354) with videos related to

Sort By:
Pageof 36
Pharmacoepidemiology and Drug Safety|March 26, 2011
Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signalsPernelle Noize, Haleh Bagheri, Geneviève Durrieu, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 30, 2019
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDSPatrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
The British Journal of Nutrition|July 23, 2009
Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavonesSébastien Vergne, Patrick Sauvant, Valérie Lamothe, et al.
British Journal of Clinical Pharmacology|August 22, 2016
Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility studyLudivine Orriols, Audrey Luxcey, Benjamin Contrand, et al.
British Journal of Clinical Pharmacology|February 18, 2015
Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting systemEmanuel Raschi, Elisabetta Poluzzi, Ariola Koci, et al.
International Journal of Geriatric Psychiatry|September 2, 2011
Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly populationFabienne Bazin, Pernelle Noize, Jean-François Dartigues, et al.
British Journal of Clinical Pharmacology|March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims databasePatrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 21, 2021
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDSPatrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
Biopharmaceutics & Drug Disposition|January 19, 2006
Myocardium distribution of sertindole and its metabolite dehydrosertindole in guinea-pigsMireille Canal-Raffin, Karine Titier, Evelyne Déridet, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Pageof 36